$0.87 EPS Expected for KMG Chemicals, Inc. (KMG); 12 Bullish Analysts Covering Evolent Health, Inc. (EVH)

May 18, 2018 - By Marie Mckinney

Evolent Health, Inc. (NYSE:EVH) Logo

Among 14 analysts covering Evolent Health (NYSE:EVH), 12 have Buy rating, 0 Sell and 2 Hold. Therefore 86% are positive. Evolent Health had 43 analyst reports since August 7, 2015 according to SRatingsIntel. As per Friday, July 7, the company rating was maintained by Jefferies. The rating was maintained by Jefferies on Thursday, November 2 with “Buy”. The firm earned “Buy” rating on Thursday, November 16 by Leerink Swann. SunTrust maintained the stock with “Buy” rating in Wednesday, September 20 report. The stock of Evolent Health, Inc. (NYSE:EVH) earned “Buy” rating by Canaccord Genuity on Wednesday, February 28. KeyBanc Capital Markets maintained the shares of EVH in report on Wednesday, January 10 with “Buy” rating. The stock of Evolent Health, Inc. (NYSE:EVH) earned “Overweight” rating by JP Morgan on Monday, March 14. The rating was upgraded by Wells Fargo on Friday, January 13 to “Outperform”. Robert W. Baird maintained Evolent Health, Inc. (NYSE:EVH) rating on Monday, May 14. Robert W. Baird has “Buy” rating and $2500 target. The stock has “Buy” rating by Canaccord Genuity on Wednesday, January 6. See Evolent Health, Inc. (NYSE:EVH) latest ratings:

14/05/2018 Broker: Robert W. Baird Rating: Buy New Target: $25.0000 Maintain
24/04/2018 Broker: JP Morgan Old Rating: Overweight New Rating: Neutral Reinitiate
24/04/2018 Broker: J.P. Morgan Rating: Hold New Target: $17.0000 Downgrade
28/02/2018 Broker: Canaccord Genuity Old Rating: Buy New Rating: Buy Old Target: $27 New Target: $24 Maintain
28/02/2018 Broker: Wells Fargo Rating: Outperform Old Target: $27 New Target: $20 Maintain
13/02/2018 Broker: Jefferies Rating: Buy New Target: $22.0 Maintain
11/01/2018 Broker: Robert W. Baird Rating: Buy New Target: $25.0 Maintain
10/01/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $19.0 Maintain
02/01/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $30.0 Maintain
11/12/2017 Broker: Canaccord Genuity Rating: Buy New Target: $27.0 Maintain

Analysts expect KMG Chemicals, Inc. (NYSE:KMG) to report $0.87 EPS on June, 8.They anticipate $0.34 EPS change or 64.15% from last quarter’s $0.53 EPS. KMG’s profit would be $13.49 million giving it 19.65 P/E if the $0.87 EPS is correct. After having $1.04 EPS previously, KMG Chemicals, Inc.’s analysts see -16.35% EPS growth. The stock increased 3.57% or $2.36 during the last trading session, reaching $68.38. About 123,920 shares traded or 6.44% up from the average. KMG Chemicals, Inc. (NYSE:KMG) has risen 41.92% since May 18, 2017 and is uptrending. It has outperformed by 30.37% the S&P500.

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides healthcare delivery and payment solutions in the United States. The company has market cap of $1.53 billion. It operates as a managed services firm that supports integrated health systems in migration toward value care and population health management. It currently has negative earnings. The companyÂ’s services include providing clients with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services, and comprehensive health plan administration services.

Another recent and important Evolent Health, Inc. (NYSE:EVH) news was published by Seekingalpha.com which published an article titled: “Bright Lights On Capitalist Woodstock, Tech Developers And Sports Betting” on May 05, 2018.

It closed at $19.65 lastly. It is down 34.82% since May 18, 2017 and is downtrending. It has underperformed by 46.37% the S&P500.

Among 6 analysts covering KMG Chemicals (NYSE:KMG), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. KMG Chemicals had 10 analyst reports since August 12, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Monday, August 31 by Zacks. Gabelli upgraded the stock to “Buy” rating in Monday, May 1 report. The firm earned “Buy” rating on Thursday, February 22 by Seaport Global. On Wednesday, December 13 the stock rating was maintained by KeyBanc Capital Markets with “Buy”. Seaport Global Securities upgraded KMG Chemicals, Inc. (NYSE:KMG) rating on Friday, December 11. Seaport Global Securities has “Buy” rating and $26 target. Gabelli downgraded the shares of KMG in report on Wednesday, December 14 to “Hold” rating. The rating was downgraded by Zacks on Wednesday, August 12 to “Strong-Buy”. Global Hunter Securities upgraded the stock to “Neutral” rating in Wednesday, August 26 report.

KMG Chemicals, Inc., through its subsidiaries, makes, formulates, and distributes specialty chemicals and performance materials worldwide. The company has market cap of $1.06 billion. The company's Electronic Chemicals segment is involved in the sale of high purity process chemicals primarily to etch and clean silicon wafers in the production of semiconductors, photovoltaics, and flat panel displays. It has a 21.43 P/E ratio. This segment's products include sulfuric, phosphoric, and nitric and hydrofluoric acids; ammonium hydroxide; hydrogen peroxide; isopropyl alcohol; other specialty organic solvents; and various blends of chemicals.

Since December 11, 2017, it had 0 insider purchases, and 15 insider sales for $28.06 million activity. $2.92M worth of stock was sold by HATCHER DAVID L on Monday, January 8. GONSER CHRISTOPHER W had sold 6,000 shares worth $396,000.

Investors sentiment increased to 1.65 in 2017 Q4. Its up 0.70, from 0.95 in 2017Q3. It improved, as 21 investors sold KMG Chemicals, Inc. shares while 30 reduced holdings. 35 funds opened positions while 49 raised stakes. 11.87 million shares or 40.19% more from 8.47 million shares in 2017Q3 were reported. Symphony Asset Mngmt Limited Liability Corp accumulated 0.02% or 3,717 shares. Jpmorgan Chase reported 71,107 shares. Vanguard Gru Incorporated owns 562,076 shares for 0% of their portfolio. Bancshares Of New York Mellon has invested 0% of its portfolio in KMG Chemicals, Inc. (NYSE:KMG). Tower Research Ltd Llc (Trc) reported 200 shares. Us Bancshares De reported 17,657 shares. Public Employees Retirement Sys Of Ohio reported 9,043 shares. Arrowmark Colorado Hldgs Limited Liability holds 0.15% or 222,521 shares. Gradient Limited Liability owns 600 shares. Aqr Cap Mngmt Limited Liability Com reported 11,790 shares or 0% of all its holdings. Penn Cap Management accumulated 22,297 shares. Stratos Wealth Prtn holds 5 shares. Brinker Cap Inc owns 4,115 shares or 0.01% of their US portfolio. Citigroup holds 0% or 5,761 shares in its portfolio. Ameritas Investment reported 1,078 shares.

KMG Chemicals, Inc. (NYSE:KMG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Marie Mckinney

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: